Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Molecular Pharmacology|November 18, 2015
Arsenic Attenuates GLI Signaling, Increasing or Decreasing its Transcriptional Program in a Context-Dependent MannerBin Li, Camilla Giambelli, Bo Tang, et al.Journal of Pancreatic Cancer|December 13, 2021
Cobimetinib Plus Gemcitabine: An Active Combination in KRAS G12R-Mutated Pancreatic Ductal Adenocarcinoma Patients in Previously Treated and Failed Multiple ChemotherapiesBach Ardalan, Jose Azqueta, Danny SleemanJournal of Cancer Research and Clinical Oncology|June 19, 2004
Effects of oxaliplatin and CPT-11 on cytotoxicity and nucleic acid incorporation of the fluoropyrimidinesManish Patel, Ram Agarwal, Bach ArdalanCancer Biology & Therapy|March 10, 2009
Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or raltitrexedElena Di Gennaro, Francesca Bruzzese, Stefano Pepe, et al.Anticancer Research|June 10, 2010
Arsenic trioxide suppresses thymidylate synthase in 5-FU-resistant colorectal cancer cell line HT29 In Vitro re-sensitizing cells to 5-FUPochi Ramalingam Subbarayan, Kelvin Lee, Bach ArdalanFrontiers in Oncology|February 7, 2024
Case report: Diagnosis of NUT carcinoma of hepatic origin by next-generation sequencingBach Ardalan, Jose Azqueta, Jia Luo, et al.International Journal of Surgery Case Reports|December 16, 2021
Pancreatic cancer presenting as bowel obstruction and role of next generation sequencing: A case reportBach Ardalan, Jose Azqueta, Jonathan England, et al.Molecular Immunology|April 18, 2006
Mapping and molecular characterization of novel monoclonal antibodies to conformational epitopes on NH2 and COOH termini of mammalian tryptophanyl-tRNA synthetase reveal link of the epitopes to aggregation and Alzheimer's diseaseElena L Paley, Larisa Smelyanski, Vladimir Malinovskii, et al.BMJ Case Reports|November 30, 2017
Treatment of advanced colorectal cancer in a patient with cardiotoxic reactions to 5-fluorouracil and capecitabine using suboptimal dosesJoseph H Cioffi, Derek J Estes, Vaia Florou, et al.Cold Spring Harbor Molecular Case Studies|October 20, 2021
Potential benefit of treatment with MEK inhibitors and chemotherapy in BRAF-mutated KRAS wild-type pancreatic ductal adenocarcinoma patients: a case reportBach Ardalan, Jose Ignacio Azqueta, Jonathan England, et al.Pageof 4